Literature DB >> 29864918

Antiapoptotic role of the cellular repressor of E1A-stimulated genes (CREG) in retinal photoreceptor cells in a rat model of light-induced retinal injury.

Tian-Zi Zhang1, Ting Hua1, Li-Kun Han1, Yan Zhang2, Guang-Yu Li2, Qiu-Li Zhang3, Guan-Fang Su4.   

Abstract

OBJECTIVE: Light injury-induced apoptosis of retinal photoreceptor cells can lead to vision loss. The mechanism underlying such injury remains unclear, and there are no effective therapies at present. The aim of this study was to examine the potential antiapoptotic role of the cellular repressor of E1A-stimulated genes (CREG) in retinal cells in a rat model of light-induced retinal damage.
METHODS: CREG proteins were injected into the vitreous space of rats in which light retinal injury was induced. An equal volume of PBS was injected into the vitreous space of a control group. Retinas were collected for H&E staining and Western blotting analysis 1, 3, and 7 days later. Inhibitors or agonist for P38, JNK, and AKT were injected into the vitreous space to verify CREG function.
RESULTS: In rats with light-induced retinal injury, the CREG treatment inhibited the expression of apoptosis-related proteins caspase-3, caspase-8, and caspase-9 and signaling proteins phosphorylated ERK (P-ERK), phosphorylated JNK (P-JNK), phosphorylated P38 (P-P38), and phosphorylated AKT (P-AKT). An inhibitor of PI3K-AKT and an agonists of P38 and JNK abrogated the inhibitory effect of CREG on caspase-3 expression.
CONCLUSION: CREG protected retinal cells against apoptosis by inhibiting P38/MAPK and JNK/MAPK signaling pathways and activating the PI3K-AKT signaling pathway.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  AKT; CREG; JNK; P38; Retinal light injury

Mesh:

Substances:

Year:  2018        PMID: 29864918     DOI: 10.1016/j.biopha.2018.04.081

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  2 in total

1.  Huperzine A lowers intraocular pressure via the M3 mAChR and provides retinal neuroprotection via the M1 mAChR: a promising agent for the treatment of glaucoma.

Authors:  Ping Yu; Wen-Pei Dong; Ya-Bin Tang; Hong-Zhuan Chen; Yong-Yao Cui; Xiao-Lan Bian
Journal:  Ann Transl Med       Date:  2021-02

2.  Hepatocyte-specific deletion of cellular repressor of E1A-stimulated genes 1 exacerbates alcohol-induced liver injury by activating stress kinases.

Authors:  Miaomiao Wu; Fan Yin; Xiaoli Wei; Ruixue Ren; Chongqing Chen; Menghua Liu; Ruyu Wang; Liu Yang; Ruiqian Xie; Shanyue Jiang; Ziming Wang; Rui Liu; Wentao Xu; Xuefu Wang; Jing Li; Hua Wang
Journal:  Int J Biol Sci       Date:  2022-01-31       Impact factor: 6.580

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.